JP2010519194A5 - - Google Patents

Download PDF

Info

Publication number
JP2010519194A5
JP2010519194A5 JP2009549471A JP2009549471A JP2010519194A5 JP 2010519194 A5 JP2010519194 A5 JP 2010519194A5 JP 2009549471 A JP2009549471 A JP 2009549471A JP 2009549471 A JP2009549471 A JP 2009549471A JP 2010519194 A5 JP2010519194 A5 JP 2010519194A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
isolated binding
hcdr3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009549471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010519194A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2008/000524 external-priority patent/WO2008099188A1/en
Publication of JP2010519194A publication Critical patent/JP2010519194A/ja
Publication of JP2010519194A5 publication Critical patent/JP2010519194A5/ja
Pending legal-status Critical Current

Links

JP2009549471A 2007-02-15 2008-02-15 ＩｇＥ分子に対する結合要素 Pending JP2010519194A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90130507P 2007-02-15 2007-02-15
PCT/GB2008/000524 WO2008099188A1 (en) 2007-02-15 2008-02-15 Binding members for ige molecules

Publications (2)

Publication Number Publication Date
JP2010519194A JP2010519194A (ja) 2010-06-03
JP2010519194A5 true JP2010519194A5 (enExample) 2011-03-24

Family

ID=39522300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009549471A Pending JP2010519194A (ja) 2007-02-15 2008-02-15 ＩｇＥ分子に対する結合要素

Country Status (8)

Country Link
US (1) US20110212084A1 (enExample)
EP (2) EP2592094A1 (enExample)
JP (1) JP2010519194A (enExample)
KR (1) KR20090114397A (enExample)
CN (1) CN101687932A (enExample)
AU (1) AU2008215926B2 (enExample)
CA (1) CA2677597A1 (enExample)
WO (1) WO2008099188A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099188A1 (en) * 2007-02-15 2008-08-21 Astrazeneca Ab Binding members for ige molecules
AR065368A1 (es) 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige
US9187568B2 (en) 2009-05-07 2015-11-17 Stallergenes S.A. Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route
JP6519913B2 (ja) * 2015-02-05 2019-05-29 国立大学法人名古屋大学 ＩｇＥ結合性エピトープペプチドの利用
TWI691512B (zh) 2015-02-20 2020-04-21 日商橘生藥品工業股份有限公司 Ｆｃ融合高親和性ＩｇＥ受體α鏈
US11896619B2 (en) * 2020-03-10 2024-02-13 Massachusetts Institute Of Technology Compositions and methods for immunotherapy of NPM1c-positive cancer
CN112023062A (zh) * 2020-09-18 2020-12-04 北京基因安科技有限公司 一个用可溶性IgE受体抑制过敏反应的方法
US20260035484A1 (en) * 2021-10-29 2026-02-05 Longbio Pharma (Suzhou) Co., Ltd. Isolated antigen binding protein and use thereof
CN117003872A (zh) * 2022-04-28 2023-11-07 北京天广实生物技术股份有限公司 含有突变轻链可变区骨架的单链抗体片段

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6172213B1 (en) * 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
CN1289253A (zh) * 1998-01-29 2001-03-28 泰诺士公司 以lgE拮抗剂治疗特应性皮炎
BR0008963A (pt) * 1999-02-25 2001-11-27 Smithkline Beecham Biolog Epìtopos ou mimótopos derivados do domìnio dec-epsilon-2 de ige, antagonistas destes, e seususos terapêuticos
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds
US20050169909A1 (en) * 2004-02-02 2005-08-04 Sanjaya Singh Identification of novel IgE epitopes
JP2008507474A (ja) * 2004-02-02 2008-03-13 タノックス インコーポレイテッド 新規のＩｇＥエピトープの同定
WO2008099188A1 (en) * 2007-02-15 2008-08-21 Astrazeneca Ab Binding members for ige molecules
AR065368A1 (es) * 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige

Similar Documents

Publication Publication Date Title
RU2012130841A (ru) СВЯЗУЮЩИЕ ЭЛЕМЕНТЫ ДЛЯ МОЛЕКУЛЫ IgE
JP2018521691A5 (enExample)
CN101611057B (zh) 人il-17的抗体分子
JP2018064560A5 (enExample)
JP2014508511A5 (enExample)
RU2495050C2 (ru) Связующий элемент для рецептора gm-csf
RU2013123927A (ru) ЭЛЕМЕНТ, СВЯЗЫВАЮЩИЙСЯ С α-РЕЦЕПТОРОМ ИНТЕРЛЕЙКИНА-4 (IL-4α)-173
EA200801520A1 (ru) Химерные и гуманизированные антитела против человеческого интерлейкина-13 (il-13)
RU2011122720A (ru) Члены связывания против il-1r1
JP2016522168A5 (enExample)
HRP20191824T1 (hr) Agonistička sredstva za vezivanje tnf receptora
HRP20171198T1 (hr) Monoklonsko protutijelo protiv psećeg interleukina-31
US20180215820A1 (en) Anti-pd-l1 antibodies for cns diseases
RU2012123148A (ru) Новые анти-il-13 антитела и их использование
RU2015141529A (ru) Антитела и биспецифические антитела к il-4 и их применение
JP2020537520A5 (enExample)
HRP20130204T1 (hr) Monoklonalna protutijela koja se vežu na hgm-csf i medicinski sastavi koji ih sadrže
JP2008527989A5 (enExample)
WO2007036745A3 (en) Interleukin-13 antibody composition
WO2008094992A3 (en) 2-aminopyridine derivatives useful as kinase inhibitors
RU2014147773A (ru) Человеческие антитела с высокой аффинностью к рецепторам il-4 человека
HRP20170324T1 (hr) Ljudska antitijela visokog afiniteta za ljudski 2 proteazom aktivirani receptor
JP2009545325A5 (enExample)
ME00519B (me) Antitijela visokog afiniteta prema humanom il-6 receptoru
UA102994C2 (ru) АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧНО СВЯЗЫВАЕТСЯ С IgE/M1' И ИНДУЦИРУЕТ АПОПТОЗ В ЭКСПРЕССИРУЮЩИХ IgE В-КЛЕТКАХ